Metropolis Healthcare Limited, India's leading diagnostic service provider, launched the Next Best Action (NBA) initiative to educate patients about chronic diseases. The NBA initiative uses data from a comprehensive study of 1,50,261 adults who underwent general body check-ups under the TruHealth package by Metropolis from 2019 to 2022. It aims to empower patients to take control of their health and avoid complications associated with chronic conditions. The initiative recommends follow-up tests based on the latest research and guidelines, providing a comprehensive assessment of various body systems.

For instance, patients with elevated blood glucose levels receive advice for diabetes monitoring tests, cardiac risk assessment, and Diabetes complication assessment based on the laboratory results and trends. This approach utilizes data science, enabling a better understanding of their diabetes-related complications and guiding their treatment journey. Regular diabetes check-ups are also emphasized to monitor blood glucose levels effectively. With the help of data analytics, it is possible to identify and monitor prediabetics according to ADA (American Diabetic Association) guidelines.

Diabetes is a chronic disease that poses a severe threat to public health, with 1 in 9 people or 640 million individuals expected to be affected by 2030. Shockingly, almost half of the cases will remain undiagnosed, leading to severe complications. Diabetic patients are at risk of kidney complications, with almost 10% of diabetics affected by high serum creatinine levels. Renal function tests are essential to monitor kidney health.

Heart health is another crucial aspect affected by high blood sugar levels. Around 92,319 patients underwent lipid profile tests, revealing that a significant number of diabetics and pre-diabetics were at risk of heart diseases due to abnormal lipid and cholesterol levels. Elevated LDL (bad cholesterol), low HDL (good cholesterol), and high triglycerides, when combined with diabetes, pose potential risks for coronary arterial diseases, strokes, and peripheral vascular diseases.

Commenting on the launch of the initiative, Surendran Chemmenkotil, Chief Executive Officer, Metropolis Healthcare Limited, said, "We at Metropolis are committed to raising awareness about the alarming trends in chronic health conditions and the importance of timely diagnosis, lifestyle modifications, and patient education. Our Next Best Action Initiative is a proactive step towards early detection and management of complications arising from chronic illnesses, enabling patients to achieve better health outcomes and improve their quality of life".